Finding the right teicoplanin dose for blood cancer or critical illness
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how the antibiotic teicoplanin is processed in the body of patients with blood cancers or critical illness. The goal is to find the right dose for each person to better treat infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 20 years old.
- You have a blood cancer (such as leukemia or lymphoma) or are critically ill.
- You are being given the antibiotic teicoplanin for a fever that may be caused by a bacterial infection.
- You have been on teicoplanin for more than 48 hours.
- You are not on kidney dialysis or had dialysis in the last two days.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the best time to start powerful antibiotics in blood cancer patients who are at high risk for infection with carbapenem-resistant bacteria. It aims to improve treatment success and reduce complications.
This study tests a new way to check if you are allergic to the antibiotic teicoplanin using your own blood serum. It aims to help doctors know for sure if you had a severe allergic reaction during a past surgery.
This trial compares two antibiotics (ceftolozane/tazobactam vs. piperacillin/tazobactam) for treating a bloodstream infection in people with blood cancer who have a very low white blood cell count and a fever. The goal is to see which antibiotic works better.
This trial tests whether using a blood test called 'PCT' can help doctors decide when to start or stop antibiotics in critically ill adult patients in the EICU. The goal is to reduce unnecessary antibiotic use while still effectively treating bacterial infections.
This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.
This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.
Hear when a new Hematological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.